Back to results
US 2019/0031773 A1Published application
Inhibitors and antagonists of human pycr1
AssigneesAgency for Science, Technology and Research, Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
InventorsSylvia GRÜNEWALD, Michael STECKEL, Manfred HUSEMANN, Hanna MEYER, Weiping HAN, Zhaobing DING
Life of this patent
Estimating the term…
Abstract
The present invention is related to an antagonist of PYCR1 for the treatment and/or prevention of a neoplastic disease.
Claims20
An antagonist of PYCR1 for the treatment and/or prevention of a neoplastic disease.
Dependencies are inferred from the claim text.